Advertisement

Polyarteritis Nodosa

  • John H. Stone
Chapter

Abstract

Polyarteritis nodosa (PAN) primarily affects medium-sized arteries that supply the skin, gut, nerve, and kidney. However, multiple other organs can be involved either clinically or subclinically. Microaneurysms of arteries to or within the kidneys, liver, or gastrointestinal tract are highly characteristic of PAN. Mononeuritis multiplex, an asymmetric sensory and motor neuropathy due to ischemia and infarction of peripheral nerves, occurs frequently in PAN. In mononeuritis multiplex, nerve conduction studies of peripheral nerves reveal a distal, asymmetric, axonal neuropathy involving both motor and sensory nerves. PAN is characterized pathologically by patchy, trans-mural inflammation in medium- and small-sized muscular arteries, sparing large arteries, capillaries, and the venous system. The inflammation leads to fibrinoid necrosis, but is not associated with granulomatous features. High-dose glucocorticoids are the mainstay of therapy in PAN. In cases that are rapidly progressive or life or organ threatening, however, cyclophosphamide is added to glucocorticoid treatment.

Keywords

Systemic Lupus Erythematosus Giant Cell Arteritis Polycythemia Vera Pyoderma Gangrenosum Nerve Biopsy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Arepally GM, Ortel TL. Heparin-induced thrombocytopenia. N Engl J Med. 2006;355:809–17PubMedCrossRefGoogle Scholar
  2. Bazari H, Jaff MR, Mannstadt M, Yan S. Case 7-2007: a 59 year-old woman with diabetic renal disease and nonhealing skin ulcers. N Engl J Med. 2007; 356:1049–57PubMedCrossRefGoogle Scholar
  3. Callen JP. Livedoid vasculopathy: what it is and how the patient should be evaluated and treated. Arch Dermatol. 2006;142:1481–2PubMedCrossRefGoogle Scholar
  4. Coffman TM, Crowley SD. Kidney in hypertension: Guyton redux. Hypertension 2008;51:811–16PubMedCrossRefGoogle Scholar
  5. Collins MP, Mendell JR, Periquet MI, et al Superficial peroneal nerve/ peroneus brevis muscle biopsy in vasculitic neuropathy. Neurology 2000;55:636–43PubMedCrossRefGoogle Scholar
  6. Ehrmann S. Ein Gefaessprozess Bei Lues. Wien Med Wochenschr. 1907;57:777Google Scholar
  7. Frances C, Niang S, Laffitte E, et al Dermatologic manifestations of the antiphospholipid syndrome. Arthritis Rheum. 2005;52: 1785–93PubMedCrossRefGoogle Scholar
  8. Frances C, Piette JC. The mystery of Sneddon's syndrome: the relationship with antiphospholipid syndrome and systemic lupus erythema-tosus. J Autoimmun. 2000;15:139–43PubMedCrossRefGoogle Scholar
  9. Frances C, Papo T, Wechser B, et al Sneddon's syndrome with and without aPL. Medicine 1999;78:209–19PubMedCrossRefGoogle Scholar
  10. Gorson KC, Hedley-White ET, Skinner MM. Case records of the Massachusetts General Hospital. N Eng J Med. 2001;344: 917–23CrossRefGoogle Scholar
  11. Guillevin L, Lhote F. Treatment of polyarteritis nodosa and microscopic polyangiitis. Arthritis Rheum. 1998;41:2100–5PubMedCrossRefGoogle Scholar
  12. Guillevin L, Cohen P, Mahr A, et al Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclo-phosphamide pulses in sixty-five patients. Arthritis Rheum. 2003; 49:93–100PubMedCrossRefGoogle Scholar
  13. Ha C, Nousari, HC. Double trephine punch biopsy technique for sampling subcutaneous tissue. J Am Acad Dermatol. 2003;48:609–10PubMedCrossRefGoogle Scholar
  14. Hairston BR, Davis MD, Pittelkow MR, Ahmed I. Livedoid vasculopa-thy: further evidence for procoagulant pathogenesis. Arch Dermatol. 2006;142:1413–8PubMedCrossRefGoogle Scholar
  15. Kroshinsky D, Stone JH, Bloch D, Sepehr A. A 47 year-old woman with numbness and pain in the lower extremities. N Engl J Med. 2009; 360:711–20PubMedCrossRefGoogle Scholar
  16. Kussmaul A, Maier R. Über eine bisher nicht beschriebene eigenthum-liche arterienerkrankung (periarteritis nodosa), die mit morbus brightii und rapid fortschreitender allgemeiner muskellahmung ein-hergeht. Dtsch Arch Klin Med. 1866;1:484–518Google Scholar
  17. London NJ, Donnelly R. ABC of arterial and venous disease: ulcerated lower limb. BMJ 2000;320:1589–91PubMedCrossRefGoogle Scholar
  18. Maessen-Visch M, Koedam M, Hamulyak K, et al Atrophie blanche. Int J Dermatol. 1999;38:161–72PubMedCrossRefGoogle Scholar
  19. Mathew L, Talbot K, Love S, et al Treatment of vasculitic peripheral neuropathy: a retrospective analysis of outcome. QJM 2007; 100:41–57PubMedCrossRefGoogle Scholar
  20. Matsumoto T, Homma S, Okada M, et al The lung in polyarteritis nodosa: a pathologic study of 10 cases. Hum Pathol. 1993;24:717–24PubMedCrossRefGoogle Scholar
  21. Mimouni D, Ng PP, Rencic A, et al Cutaneous PAN in patients presenting with atrophie blanche. Br J Dermatol. 2003;148:789–94PubMedCrossRefGoogle Scholar
  22. Pagnoux C, Seror R, Mahr A, et al Polyarteritis nodosa: clinical description and long-term follow-up of the 351 patients from the French Vasculitis Study Group. Arthritis Rheum. 2006;49:S420Google Scholar
  23. Stockhammer GJ, Felber SR, Zelger B, et al Sneddon's syndrome: diagnosis by skin biopsy and MRI in 17 patients. Stroke 1993;24:685–90PubMedCrossRefGoogle Scholar
  24. Stone JH, Talor M, Stebbing J, et al Test characteristics of immunofluo-rescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions. Arthritis Care Res. 2000;13: 424–34PubMedCrossRefGoogle Scholar
  25. Stone JH, Nousari HC. “Essential” cutaneous vasculitis: what every rheumatologist should know about vasculitis of the skin. Curr Opin Rheumatol. 2001;13:23–34PubMedCrossRefGoogle Scholar
  26. Talor M V, Stone JH, Stebbing JJ, et al Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA) by immunofluorescence antibodies to minor target antigens in patients with anti-neutrophil cytoplasmic antibodies. Clin Exp Immunol. 2007;150:42–8PubMedCrossRefGoogle Scholar
  27. Uthman IW, Khamashta MA. Livedo racemosa: a striking dermatological sign for the antiphospholipid syndrome. J Rheumatol. 2006;33: 2379–82PubMedGoogle Scholar
  28. Vallat J-M, Cros DP, Hedley-White ET. Case 9-2007: a 27 year-old woman with pain and swelling of the legs. N Engl J Med. 2007;356: 1252–9PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  • John H. Stone
    • 1
  1. 1.Massachusetts General HospitalRheumatology

Personalised recommendations